Dr. Cassel will discuss the challenges of caring for frailty, the power of the aging demographic, and how technology can enhance care and engagement in society for older Americans.

Boston is ranked #9 on the Milken Institute’s Best Cities for Successful Aging 2017 Report. What is needed to bring models that enable successful aging in cities like Boston to scale regionally and nationally? What makes it such a good place for successful aging? What can other cities learn from it? Given the healthcare-policy gridlock in Washington, what opportunities exist for localities to innovate in this area?

David Klein
Special Advisor to CEO, URMC
*moderator

Melanie Bella
Chief of New Business and Policy, Cityblock Health

Krista Drobac
Executive Director, Alliance for Connected Care

Sandy Markwood
CEO, National Association of Area Agencies on Aging

Kedar Mate
Chief Innovation Officer, Institute for Healthcare Improvement

At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, and today has the leading portfolio of medicines to treat multiple sclerosis; has introduced the first and only approved treatment for spinal muscular atrophy; and is focused on advancing neuroscience research programs in Alzheimer’s disease and dementia, multiple sclerosis and neuroimmunology, movement disorders, neuromuscular disorders, pain, ophthalmology, neuropsychiatry, and acute neurology. Biogen also manufactures and commercializes biosimilars of advanced biologics.

West Health will bring together experts in aging and healthcare to explore the business case and value proposition for investing in and advancing innovative care models, programs and initiatives to enable successful aging.

Chris Burke
Founder,
Collaboration, Inc.
*moderator

Efrem Castillo
Chief Medical Officer, UnitedHealthcare Medicare & Retirement

Timothy Lash
Chief Strategy Officer & EVP, Successful Aging, West Health;
President, West Health Policy Center

Nora Super
Director, Policy & Programs, Center for the Future of Aging, Milken Institute

Charlotte Yeh
Chief Medical Officer, AARP Services, Inc.

Founded in 1912, Visiting Nurse Association (VNA) Health Group is New Jersey’s largest and the nation’s second largest not-for-profit visiting nurse association. Each year we help more than 120,000 individuals and families –with a special focus on vulnerable populations –achieve their best level of health and well-being by providing home health, hospice, palliative and community-based care and private-pay personal care. A full range of primary-care and dental services are available through VNACJ CommunityHealth Centers, a Federally Qualified Health Center (FQHC), and “house call” visiting physician services for individuals with limited mobility. Our joint-venture partnerships with health systems leverage clinical and technical resources to operate Robert Wood Johnson Visiting Nurses, VNA of Englewood and VNA Health Group of New Jersey (Barnabas Health Home Care and Hospice, VNA of Central Jersey Home Care and Hospice). Through our Advanced Care Institute, VNA Health Group promotes palliative care and home-based primary care to facilitate the highest quality of life for individuals facing late stages of chronic illness. Our Connected Health Institute drives innovation in the development of digital and mobile technology to link patients, caregivers and clinicians.

Dan Gebremedhin
Principal, Flare Capital Partners

Jody Holtzman
Sr. Managing Partner, Longevity Venture Advisors

Carolyn Magill
CEO, Aetion

A number of recent partnerships and initiatives have focused on using technology to improve the physical delivery of health solutions, such as Lyft’s alliances with CVS and AllScripts, and Amazon’s expansion of Prime Services to Medicaid beneficiaries. Is this likely to continue, and are there other areas ripe for such technological disruption? What is the importance of reaching across disciplines to forge new alliances, devise practical policy solutions and disrupt current care models?

Laura Landro
Contributor, Wall Street Journal
*moderator

Joseph Coughlin
Founder and Director, MIT AgeLab

Mary Modahl
Senior VP and Chief Marketing Officer, American Well

Timothy Peck
CEO, Call9

Matt Patterson
President, Welbe Health

The Simon Business School is currently ranked among the leading graduate business schools in the world in rankings published by the popular press, including Bloomberg Business week, U.S. News & World Report, and the Financial Times. The Financial Times recently rated the School No. 2 in the world for finance. More information about Simon Business School is available at www.simon.rochester.edu.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best‐known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us.